Insider Activity of Dahan Michel
Biography of Dahan Michel
No biography is available at this moment.
No biography is available at this moment.
| 2024-05-13 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 34,840 0.0162% | $1.26 | $43,898 | +34.11% | |
| 2024-02-29 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 8,661 0.0046% | $1.58 | $13,684 | -7.28% | |
| 2024-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 10,744 0.0053% | $1.52 | $16,331 | -10.37% | |
| 2023-05-25 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 95,478 0.0522% | $1.22 | $116,760 | +3.31% | |
| 2023-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 20,412 0.0107% | $0.88 | $17,912 | +23.5% | |
| 2023-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 10,090 0.0055% | $0.81 | $8,205 | +38.48% | |
| 2022-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 14,978 0.0084% | $2.17 | $32,513 | -80.93% | |
| 2022-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 6,555 0.0036% | $2.15 | $14,125 | -81.02% | |
| 2021-04-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 1,211 0.0008% | $3.40 | $4,117 | -15.92% | |
| 2021-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 14,547 0.0095% | $3.40 | $49,403 | -14.84% | |
| 2020-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Operating Officer | 6,972 0.0053% | $8.70 | $60,656 | -34.16% | |
| 2017-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,796 0.0058% | $19.64 | $54,913 | -45.25% | |
| 2017-09-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 10,000 0.0214% | $19.30 | $193,000 | -43.7% | |
| 2017-08-15 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 10,000 0.0211% | $15.00 | $150,000 | -4.78% | |
| 2017-07-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,798 0.0058% | $14.26 | $39,893 | -0.51% | |
| 2017-04-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,802 0.007% | $9.18 | $25,715 | +64.77% | |
| 2017-01-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 3,258 0.0087% | $10.49 | $34,178 | +33.14% | |
| 2016-10-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,802 0.0074% | $8.95 | $25,091 | +14.17% | |
| 2016-07-05 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,804 0.0074% | $7.47 | $20,936 | +21.67% | |
| 2016-04-04 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Business Officer | 2,802 0.0073% | $9.41 | $26,367 | -7.02% |